This application describes the proposed transition of the HNRC from its current P50 structure to a P30 """"""""Center of Excellence"""""""" in neuroAIDS research. Since its initial funding as an NIMH AIDS Center in 1989, the HNRC has established itself as a leader in neuroAIDS research. Its scientific stature is reflected in the several hundred publications and scientific presentations that have communicated the work of the HNRC and its associated studies on a range of multi-disciplinary topics including incidence, prevalence, and features of neurocognitive impairment (NCI); possible molecular and cellular substrates of NCI; HIV genotypic evolution in the central nervous system; the CSF as a window of CNS events; """"""""real life"""""""" implications of NCI in terms of work, daily life, and survival: the effects of HIV disease and NCI on family and social adaptation; the therapeutics of NCI; and behavioral interventions. Evidence that the HNRC has evolved program a program whose primary focus was on performing research to one that leads and synergizes comes from the fact that the number of awards associated with the HNRC has risen from three in 1989 to 26 in 1999. In this application we envision the HNRC's development as a Center of Excellence in neuroAIDS research and education.
Our aims are to (1) help identify and clarify the critical questions for neuroAIDS research; (2) determine, develop and refine the methodologies to address these; (3) enable rapid response to emerging scientific challenges and opportunities; (4) foster collaborative transdisciplinary research; (5) provide consultation and technical assistance for investigators and trainees; (6) support innovative preliminary studies; (7) provide mentorship as well as an intellectual and physical context for training; (8) facilitate information exchange relevant to neuroAIDS. Though a scientific agenda setting process we have identified scientific themes that shall be the primary (though not exclusive) focus of the research facilitated by the HNRC. These include (1) delineating the molecular mechanisms underlying HIV CNS disease; (2) exploring the CNS as a sanctuary in HIV infection and the CSF as a window to CNS events; (3) understanding cofactors that may influence neurocognitive complications; (4) determining the real life significance of NCI; (5) developing strategies for prevention and treatment of NCI. To achieve this, the HNRC will be organized as five scientific Cores- Neuromedical, Neurobehavioral, Neurobiology, Structural Neuroimaging, Cellular Immunology and Fluids-that shall provide leadership, consultation, mentoring, and practical support. A Developmental Core is proposed to help jumpstart innovative preliminary investigations as well as to mentor young scientists. An umbrella coordinating Core, consisting of Administrative, Participant Accrual and Retention, Data Management, and Statistics Units will provide the tools to synergize the efforts of the Cores and the independent research studies they are meant to facilitate. The effectiveness of the HNRC will be evaluated through internal and external review processes, including consultations with the HNRC Scientific Advisory Board, Community Advisory Board, and Participant Advisory Board.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Center Core Grants (P30)
Project #
5P30MH062512-03
Application #
6639220
Study Section
Special Emphasis Panel (ZMH1-BRB-T (04))
Program Officer
Rausch, Dianne M
Project Start
2001-04-24
Project End
2005-11-30
Budget Start
2002-12-01
Budget End
2003-11-30
Support Year
3
Fiscal Year
2003
Total Cost
$2,109,550
Indirect Cost
Name
University of California San Diego
Department
Psychiatry
Type
Schools of Medicine
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Walker, Rheeda L; Hong, Judy H; Talavera, David C et al. (2018) Health literacy and current CD4 cell count in a multiethnic U.S. sample of adults living with HIV infection. Int J STD AIDS 29:498-504
Heldt, Sven; Prattes, Juergen; Eigl, Susanne et al. (2018) Diagnosis of invasive aspergillosis in hematological malignancy patients: Performance of cytokines, Asp LFD, and Aspergillus PCR in same day blood and bronchoalveolar lavage samples. J Infect 77:235-241
Jenks, Jeffrey Daniel; Hoenigl, Martin (2018) CD4:CD8 ratio and CD8+ cell count for prognosticating mortality in HIV-infected patients on antiretroviral therapy. J Lab Precis Med 3:
Ocque, Andrew J; Hagler, Colleen E; Morse, Gene D et al. (2018) Development and validation of an LC-MS/MS assay for tenofovir and tenofovir alafenamide in human plasma and cerebrospinal fluid. J Pharm Biomed Anal 156:163-169
Soontornniyomkij, Virawudh; Umlauf, Anya; Soontornniyomkij, Benchawanna et al. (2018) Association of antiretroviral therapy with brain aging changes among HIV-infected adults. AIDS 32:2005-2015
Moore, Raeanne C; Hussain, Mariam A; Watson, Caitlin W-M et al. (2018) Grit and Ambition are Associated with Better Neurocognitive and Everyday Functioning Among Adults Living with HIV. AIDS Behav 22:3214-3225
Patel, Atul K; Patel, Ketan K; Gohel, Swati et al. (2018) Incidence of symptomatic CSF viral escape in HIV infected patients receiving atazanavir/ritonavir (ATV/r)-containing ART: a tertiary care cohort in western India. J Neurovirol 24:498-505
Kanmogne, Georgette D; Fonsah, Julius Y; Tang, Bin et al. (2018) Effects of HIV on executive function and verbal fluency in Cameroon. Sci Rep 8:17794
Kabuba, Norma; Menon, J Anitha; Franklin, Donald R et al. (2018) Effect of age and level of education on neurocognitive impairment in HIV positive Zambian adults. Neuropsychology 32:519-528
Gianella, Sara; Marconi, Vincent C; Berzins, Baiba et al. (2018) Genital HIV-1 Shedding With Dolutegravir (DTG) Plus Lamivudine (3TC) Dual Therapy. J Acquir Immune Defic Syndr 79:e112-e114

Showing the most recent 10 out of 743 publications